Oral contraceptives for the treatment of acne vulgaris

Journal of the American Academy of Dermatology

Volumn 56, Issue 6, 2007, Pages 1056-1057

  Heymann, Warren R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZOYL PEROXIDE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; PLACEBO; RETINOID; SPIRONOLACTONE;

ACNE VULGARIS; ARTICLE; BREAKTHROUGH BLEEDING; BREAST CANCER; BREAST TENDERNESS; CLINICAL TRIAL; DRUG MECHANISM; HEART INFARCTION; HORMONAL THERAPY; HUMAN; LABORATORY TEST; MOOD CHANGE; NAUSEA; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; STROKE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ACNE VULGARIS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS;

EID: 34248383956     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.01.027     Document Type: Article

References (6)

1. Harper J.C. Antiandrogen therapy for skin disease and hair disease. Dermatol Clin 24 (2006) 137-143
2. Shaw J.C. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol 43 (2000) 498-502
3. James W.D. Acne. N Engl J Med 352 (2005) 1463-1472
4. Arowojolu A.O., Gallo M.F., Grimes D.A., and Garner S.E. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev (2004) (3):CD004425
5. Lynde C.W. Hormonal approach to the treatment of acne: a Canadian perspective. J Cutan Med Surg 8 Suppl 4 (2004) 1-2
6. Haroun M. Hormonal therapy of acne. J Cutan Med Surg 8 Suppl 4 (2004) 6-10